Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gnosis by Lesaffre is a global leader in developing and manufacturing fermentation-derived active ingredients—including probiotics, prebiotics, nutritional yeasts, vitamins (notably vitamin K2), and specialty molecules like salidroside—for use in nutraceuticals, pharmaceuticals, functional foods/beverages. Their products have demonstrated benefits across cardiovascular health, bone/joint wellness, immunity/digestion/women’s health/cognition. The company operates under GMP standards with extensive clinical validation supporting product efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gnosis by Lesaffre.